CH616425A5 - - Google Patents
Download PDFInfo
- Publication number
- CH616425A5 CH616425A5 CH751576A CH751576A CH616425A5 CH 616425 A5 CH616425 A5 CH 616425A5 CH 751576 A CH751576 A CH 751576A CH 751576 A CH751576 A CH 751576A CH 616425 A5 CH616425 A5 CH 616425A5
- Authority
- CH
- Switzerland
- Prior art keywords
- added
- solution
- mixture
- indolo
- minutes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7519960A FR2315277A1 (fr) | 1975-06-25 | 1975-06-25 | Nouveaux derives pentacycliques, leur preparation et les compositions qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
CH616425A5 true CH616425A5 (ko) | 1980-03-31 |
Family
ID=9157046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH751576A CH616425A5 (ko) | 1975-06-25 | 1976-06-14 |
Country Status (17)
Country | Link |
---|---|
US (1) | US4138489A (ko) |
JP (1) | JPS6039679B2 (ko) |
AU (1) | AU496905B2 (ko) |
BE (1) | BE843215A (ko) |
CH (1) | CH616425A5 (ko) |
DE (1) | DE2627190A1 (ko) |
DK (1) | DK285576A (ko) |
ES (1) | ES449209A1 (ko) |
FR (1) | FR2315277A1 (ko) |
GB (1) | GB1543807A (ko) |
HU (1) | HU174882B (ko) |
IE (1) | IE43138B1 (ko) |
IL (1) | IL49864A0 (ko) |
LU (1) | LU75242A1 (ko) |
NL (1) | NL7606884A (ko) |
SE (1) | SE420730B (ko) |
ZA (1) | ZA763779B (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA786426B (en) * | 1977-11-25 | 1979-10-31 | Scras | New indulo(2,3-a)quinolizidines,preparation and therapeutic use |
US4428877A (en) | 1978-07-12 | 1984-01-31 | Richter Gedeon Vegyeszeti Gyar Rt. | Cis-10-bromo-E-homoeburnanes |
JPH0523116Y2 (ko) * | 1988-07-29 | 1993-06-14 | ||
FR2648817B1 (fr) * | 1989-06-21 | 1993-02-05 | Richter Gedeon Vegyeszet | Nouveau derives diester d'octahydro-indolo-(2,3-a)-tetrahydropyranyl (2,3-c) quinolizine racemiques et optiquement actifs et procede pour les preparer |
ITRM20010356A1 (it) * | 2001-06-21 | 2002-12-23 | Sigma Tau Ind Farmaceuti | "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536725A (en) * | 1967-11-22 | 1970-10-27 | Miles Lab | Cyanoethylated derivatives of 2,3,4,6,7,12-hexahydroindolo(2,3-alpha)-quinolizine |
FR2168853B1 (ko) * | 1972-01-24 | 1975-04-25 | Centre Etd Ind Pharma |
-
1975
- 1975-06-25 FR FR7519960A patent/FR2315277A1/fr active Granted
-
1976
- 1976-06-14 CH CH751576A patent/CH616425A5/fr not_active IP Right Cessation
- 1976-06-16 DE DE19762627190 patent/DE2627190A1/de not_active Ceased
- 1976-06-21 IE IE1337/76A patent/IE43138B1/en unknown
- 1976-06-21 BE BE168153A patent/BE843215A/xx not_active IP Right Cessation
- 1976-06-22 IL IL49864A patent/IL49864A0/xx unknown
- 1976-06-23 GB GB26130/76A patent/GB1543807A/en not_active Expired
- 1976-06-23 SE SE7607231A patent/SE420730B/xx unknown
- 1976-06-24 DK DK285576A patent/DK285576A/da not_active Application Discontinuation
- 1976-06-24 ZA ZA763779A patent/ZA763779B/xx unknown
- 1976-06-24 HU HU76AE468A patent/HU174882B/hu unknown
- 1976-06-24 AU AU15236/76A patent/AU496905B2/en not_active Expired
- 1976-06-24 NL NL7606884A patent/NL7606884A/xx not_active Application Discontinuation
- 1976-06-25 ES ES449209A patent/ES449209A1/es not_active Expired
- 1976-06-25 LU LU75242A patent/LU75242A1/xx unknown
- 1976-06-25 US US05/700,028 patent/US4138489A/en not_active Expired - Lifetime
- 1976-06-25 JP JP51074537A patent/JPS6039679B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS5217488A (en) | 1977-02-09 |
GB1543807A (en) | 1979-04-04 |
IE43138B1 (en) | 1980-12-31 |
BE843215A (fr) | 1976-12-21 |
US4138489A (en) | 1979-02-06 |
IL49864A0 (en) | 1976-08-31 |
LU75242A1 (ko) | 1978-01-18 |
AU496905B2 (en) | 1978-11-09 |
FR2315277A1 (fr) | 1977-01-21 |
NL7606884A (nl) | 1976-12-28 |
ES449209A1 (es) | 1977-07-16 |
HU174882B (hu) | 1980-04-28 |
SE7607231L (sv) | 1976-12-26 |
FR2315277B1 (ko) | 1979-08-10 |
IE43138L (en) | 1976-12-25 |
DK285576A (da) | 1976-12-26 |
SE420730B (sv) | 1981-10-26 |
ZA763779B (en) | 1977-06-29 |
JPS6039679B2 (ja) | 1985-09-06 |
DE2627190A1 (de) | 1977-01-20 |
AU1523676A (en) | 1978-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2716146B2 (ja) | 縮合インドール誘導体およびその製造方法 | |
EP0580502B1 (fr) | 3-(hydroxybenzylidényl)-indoline-2-ones, et les compositions pharmaceutiques qui les contiennent | |
FR2711993A1 (fr) | Médicaments contenant des dérivés de 7H-imidazol[1,2-a]pyrazine-8-one, les nouveaux composés et leur préparation. | |
CA2176668C (fr) | Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant | |
CA2104883A1 (fr) | Derives d'acide thienyl ou pyrrolyl carboxyliques, leur preparation et medicaments les contenant | |
EP0350403A1 (fr) | Dérivés de (aza)naphtalènesultame, leurs procédés de préparation et les médicaments les contenant | |
FR2662696A2 (fr) | Antagonistes de la serotonine, leur preparation et medicaments les contenant. | |
EP0708774A1 (fr) | DERIVES D'IMIDAZO [1,2-a]PYRAZIN-4-ONE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT | |
EP0789699B1 (fr) | SPIRO[HETEROCYCLE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE]-4'-ONES, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT | |
FR2700472A1 (fr) | Association synergisante ayant un effet antagoniste des récepteurs NK1 et NK2. | |
JPH0471072B2 (ko) | ||
EP0114850B1 (fr) | Nouveaux derives substitues du 2,5-diamino 1,4-diazole, leurs procedes de preparation et les compositions pharmaceutiques en renfermant | |
EP0366511A1 (fr) | Nouveaux dérivés benzoxazolinoniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent | |
CH661046A5 (fr) | Derives de benzodioxinopyrrole et procedes de preparation. | |
EP0937043B1 (fr) | Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
FR2536398A1 (fr) | Nouveaux composes heterocycliques | |
FR2602771A1 (fr) | Nouveaux derives de la benzyl-4 piperazine, leur preparation et les compositions pharmaceutiques qui les contiennent | |
CH616425A5 (ko) | ||
CA2557942C (fr) | Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique | |
FR2761071A1 (fr) | Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique | |
EP0099815B1 (fr) | Dérivés du pyridyl-3 alcoxy-(ou phénoxy- ou aralkyloxy-)5 pyrazole, procédé de préparation et application en thérapeutique | |
EA003991B1 (ru) | Производные 2-аминопиридинов, способ ингибирования синтазы оксида азота, фармацевтические композиции и способы лечения | |
JP4216337B2 (ja) | ベンゾ[g]キノリン誘導体 | |
JPH11506470A (ja) | 新規複素環式化合物 | |
US4843080A (en) | 1,12-disubstituted octahydroindolo[2,3-]quinolizine derivatives, pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |